Regulatory Updates

Clinical trial injection bottle and hypodermic needle

Singapore: GN-20: Guidance on Clinical Evaluation Revision 2

The Health Sciences Authority (HSA) Singapore published minor update of guidance document entitled GN-20 R2 Guidance on Clinical Evaluation on 01 November 2022, stipulating clinical investigations carried out by or on behalf of product owner are encouraged and expected to be designed, conducted, and reported in accordance with international ISO 14155 – Clinical

Updates

Singapore: Minor Update on GN-06: Guidance on Distribution Records

In line with GDPMDS, HSA Singapore also published minor updates of guidance document entitled GN-06 R3 Guidance on Distribution Records on 01 Nov 2022 which assist product owners on the determination of projected useful life of the medical device. Projected useful life of a medical device is dependent on various

Sign up for our regulatory roundup delivered once a month to your inbox

Scroll to Top

Contact Us

Stay Ahead in Southeast Asia's Medical Device Market!

Subscribe to our Newsletter
Be the first to receive essential updates on regulatory changes, market trends, and industry insights from us!

Andaman Medical - Mar Socials 2025 (11)